Dec 7, 2021Confidence B
Funding0 evidence links
METiS Therapeutics capital or status signal reviewed
METiS Therapeutics public source reviewed for capital or strategic-status timeline signal.
No source evidence matched to this event.Status timeline
Funding, product, customer, team, and correction signalsDec 7, 2021Confidence A
Product0 evidence links
METiS Therapeutics product scope reviewed
METiS Therapeutics public product source reviewed for category placement and current operating focus.
No source evidence matched to this event.Funding timeline
Amounts are shown only when disclosed and tied to evidence.Dec 7, 2021
Series A
AmountUndisclosed
InvestorsChina Life, PICC PE
EvidenceConfidence B
Source evidence
Public links, short factual summaries, and trust levelsMETiS Therapeutics capital or status signal
Business Wire · mediaMETiS Therapeutics public capital or strategic-status source reviewed for stage and timeline signal.
Open sourceMETiS Therapeutics official product profile
METiS Therapeutics official site · officialMETiS Therapeutics official source reviewed for product scope, operating focus, and category placement.
Open source